Journal of Medical Economics, Volume 13, Issue 3 (2010)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 13, Issue 3 (2010)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Volume 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Original Article

Article
Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis
Fredrik Borgström, Oskar Ström, Fernando Marin, Alexey Kutahov & Östen Ljunggren
Pages: 381-392
Published online: 06 Jul 2010
AbstractforCost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis | Full Text | References | PDF (222.1 KB)
  • 1112 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access
Article
Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States
Mallik Angalakuditi, Eric Edgell, Anthony Beardsworth, Erin Buysman & Tim Bancroft
Pages: 393-402
Published online: 08 Jul 2010
AbstractforTreatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States | Full Text | References | PDF (138.1 KB)
  • 2064 Views
  • 34 CrossRef citations
  • 0Altmetric
Free Access

Review Article

Review Article
Cost effectiveness of tiotropium for chronic obstructive pulmonary disease: a systematic review of the evidence
Josephine A. Mauskopf, Christine L. Baker, Brigitta U. Monz & Melissa D. Juniper
Pages: 403-417
Published online: 08 Jul 2010
AbstractforCost effectiveness of tiotropium for chronic obstructive pulmonary disease: a systematic review of the evidence | Full Text | References | PDF (285.1 KB) | Supplemental
  • 1635 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access
Review Article
A review of international pharmacoeconomic models assessing the use of aspirin in primary prevention
Lieven Annemans, Kim Wittrup-Jensen & Héctor Bueno
Pages: 418-427
Published online: 16 Jul 2010
AbstractforA review of international pharmacoeconomic models assessing the use of aspirin in primary prevention | Full Text | References | PDF (223.8 KB)
  • 865 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Cost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trial
Robert L. Ohsfeldt, Sanjay K. Gandhi, Lee J. Smolen, Marie M. Jensen, Kathleen M. Fox, Alex Gold & Judith Hsia
Pages: 428-437
Published online: 21 Jul 2010
AbstractforCost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trial | Full Text | References | PDF (430.9 KB)
  • 712 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Article
Burden of illness among patients at high risk versus low risk for major cardiovascular events
Carolyn Harley, Stephen D. Sander, Victoria Zarotsky, Feng Cao & Hemal Shah
Pages: 438-446
Published online: 21 Jul 2010
AbstractforBurden of illness among patients at high risk versus low risk for major cardiovascular events | Full Text | References | PDF (86.1 KB)
  • 210 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Economic and clinical contributions of an antimicrobial barrier dressing: a strategy for the reduction of surgical site infections
David Leaper, Jameel Nazir, Chris Roberts & Richard Searle
Pages: 447-452
Published online: 23 Jul 2010
AbstractforEconomic and clinical contributions of an antimicrobial barrier dressing: a strategy for the reduction of surgical site infections | Full Text | References | PDF (72.4 KB)
  • 494 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access

Review Article

Review Article
The cost effectiveness of palivizumab: a systematic review of the evidence
Kelly A. Smart, Krista L. Lanctôt & Bosco A. Paes
Pages: 453-463
Published online: 23 Jul 2010
AbstractforThe cost effectiveness of palivizumab: a systematic review of the evidence | Full Text | References | PDF (209.4 KB)
  • 1272 Views
  • 30 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Glatiramer acetate and interferon beta-1a for intramuscular administration: a study of outcomes among multiple sclerosis intent-to-treat and persistent-use cohorts
Jane Castelli-Haley, MerriKay A. Oleen-Burkey, Maureen J. Lage & Kenneth Johnson
Pages: 464-471
Published online: 28 Jul 2010
AbstractforGlatiramer acetate and interferon beta-1a for intramuscular administration: a study of outcomes among multiple sclerosis intent-to-treat and persistent-use cohorts | Full Text | References | PDF (165.9 KB)
  • 501 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access
Article
Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%
Noam Y. Kirson, Jasmina I. Ivanova, Howard G. Birnbaum, Robert Wei, Evan Kantor, R. Amy Puenpatom, Rami H. Ben-Joseph & Kent H. Summers
Pages: 472-481
Published online: 04 Aug 2010
AbstractforDescriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5% | Full Text | References | PDF (186.7 KB)
  • 341 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin
Noam Y. Kirson, Jasmina I. Ivanova, Howard G. Birnbaum, Robert Wei, Evan Kantor, R. Amy Puenpatom, Rami H. Ben-Joseph & Kent H. Summers
Pages: 482-491
Published online: 04 Aug 2010
AbstractforComparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin | Full Text | References | PDF (152.4 KB)
  • 620 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Budget impact model of tobramycin inhalation solution for treatment of Pseudomonas aeruginosa in cystic fibrosis patients
Tatia Chay Woodward, Ruth Brown, Patricia Sacco & Jie Zhang
Pages: 492-499
Published online: 29 Jul 2010
AbstractforBudget impact model of tobramycin inhalation solution for treatment of Pseudomonas aeruginosa in cystic fibrosis patients | Full Text | References | PDF (127 KB)
  • 567 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access
Article
Medical and cost burden of atherosclerosis among patients treated in routine clinical practice
Robert L. Ohsfeldt, Sanjay K. Gandhi, Kathleen M. Fox, Michael F. Bullano & Michael Davidson
Pages: 500-507
Published online: 02 Aug 2010
AbstractforMedical and cost burden of atherosclerosis among patients treated in routine clinical practice | Full Text | References | PDF (323 KB)
  • 1554 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access
Article
Canadian cost-effectiveness analysis of solifenacin compared to oxybutynin immediate-release in patients with overactive bladder
S. Herschorn, C. Vicente & C. Piwko
Pages: 508-515
Published online: 09 Aug 2010
AbstractforCanadian cost-effectiveness analysis of solifenacin compared to oxybutynin immediate-release in patients with overactive bladder | Full Text | References | PDF (215.2 KB)
  • 525 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden
Göran Nordström, Nicolas Despiegel, Florence Marteau, Natalya Danchenko & Khaled Maman
Pages: 516-526
Published online: 10 Aug 2010
AbstractforCost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden | Full Text | References | PDF (613.8 KB)
  • 732 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access
Article
The 6-month persistence on SSRIs and associated economic burden
Larry Ereshefsky, Delphine Saragoussi, Nicolas Despiégel, Karina Hansen, Clément François & Khaled Maman
Pages: 527-536
Published online: 11 Aug 2010
AbstractforThe 6-month persistence on SSRIs and associated economic burden | Full Text | References | PDF (174.4 KB)
  • 627 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access
Article
Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium
L. Annemans, X. Bresse, C. Gobbo & M. Papageorgiou
Pages: 537-551
Published online: 16 Aug 2010
AbstractforHealth economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium | Full Text | References | PDF (711.6 KB)
  • 1087 Views
  • 37 CrossRef citations
  • 0Altmetric
Free Access
Article
Clinical characteristics and resource utilization of patients with bipolar disorder who have frequent psychiatric interventions
J. Thomas Haskins, Wayne Macfadden, Norris Turner, Concetta Crivera, Riad Dirani, Larry Alphs, Kenneth Gersing & Bruce Burchett
Pages: 552-558
Published online: 26 Aug 2010
AbstractforClinical characteristics and resource utilization of patients with bipolar disorder who have frequent psychiatric interventions | Full Text | References | PDF (111.6 KB)
  • 258 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost effectiveness of deferasirox compared to desferrioxamine in the treatment of iron overload in lower-risk, transfusion-dependent myelodysplastic syndrome patients
K. Tolley, N. Oliver, E. Miranda, K. Migliaccio-Walle, D. Bozkaya & Q. Li
Pages: 559-570
Published online: 02 Sep 2010
AbstractforCost effectiveness of deferasirox compared to desferrioxamine in the treatment of iron overload in lower-risk, transfusion-dependent myelodysplastic syndrome patients | Full Text | References | PDF (145.7 KB)
  • 1106 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
The societal impact of pain in the European Union: health-related quality of life and healthcare resource utilization
Paul Langley, Gerhard Müller-Schwefe, Andrew Nicolaou, Hiltrud Liedgens, Joseph Pergolizzi & Giustino Varrassi
Pages: 571-581
Published online: 03 Sep 2010
AbstractforThe societal impact of pain in the European Union: health-related quality of life and healthcare resource utilization | Full Text | References | PDF (101.8 KB)
  • 1612 Views
  • 83 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Intensive care unit improves dialysis care quality while reducing costs
Tara Greenleaf Nichols et al.
Research Letter | Published online: 7 Jun 2024
Open Access
The efficiency of TAVI in intermediate and low-risk Japanese patients
Panagiotis Petrou
Editorial | Published online: 7 Jun 2024
Open Access
Analysis of long-term clinical and cost impact of etranacogene dezaparvovec for the treatment of hemophilia B population in the United States
Songkai Yan et al.
Article | Published online: 6 Jun 2024
Open Access
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Matthew Matasar et al.
Article | Published online: 6 Jun 2024
Open Access
View all latest articles